2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease.
Sign Up to like & getrecommendations! Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.06.014
Abstract: BACKGROUND AND AIMS We aimed to identify novel biomarkers for cardiovascular mortality through a non-targeted metabolomics approach in patients with established atherosclerotic disease from the Tor Vergata Atherosclerosis Registry (TVAR). METHODS We compared the serum… read more here.
Keywords: cardiovascular mortality; hydroxycaproate predicts; disease; atherosclerotic disease ... See more keywords
Updated Clinical and Radiological Classification of Lower Limb Atherosclerotic Disease.
Sign Up to like & getrecommendations! Published in 2019 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2018.06.011
Abstract: Lower limb atherosclerotic disease has classically been classified as acute or chronic; however, this is an evolving process that has a wide spectrum of clinical and imaging aspects. Owing to the evolvement of endovascular and… read more here.
Keywords: limb atherosclerotic; lower limb; disease; atherosclerotic disease ... See more keywords
Critical Appraisal of the Contemporary Use of Atherectomy to Treat Femoral-Popliteal Atherosclerotic Disease.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of vascular surgery"
DOI: 10.1016/j.jvs.2021.07.106
Abstract: OBJECTIVE Atherectomy has become increasingly used as an endovascular treatment of lower extremity atherosclerotic disease in the United States. Concerns and controversies about its indication and outcomes exist. The goal of this systematic review and… read more here.
Keywords: atherosclerotic disease; patency; atherectomy treat; atherectomy ... See more keywords
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence.
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0040-1713376
Abstract: Despite advances in secondary prevention strategies in patients with cardiovascular disease, the residual risk of recurrent atherothrombotic events remains high. Dual-antiplatelet therapy is the standard of care for secondary prevention in patients with acute coronary… read more here.
Keywords: pathway inhibition; patients atherosclerotic; atherosclerotic disease; vascular protection ... See more keywords
Proteomics for the prediction and prevention of atherosclerotic disease.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac036
Abstract: Graphical AbstractMoving from the genome to the transcriptome to the proteome reveals increasing biological complexity for understanding pathways of atherosclerotic disease and its progression. The process of gene expression in which coding DNA strands are… read more here.
Keywords: prediction prevention; proteomics prediction; prevention; atherosclerotic disease ... See more keywords
The effect of omega-3 polyunsaturated fatty acid intake on blood levels of omega-3s in people with chronic atherosclerotic disease: a systematic review.
Sign Up to like & getrecommendations! Published in 2023 at "Nutrition reviews"
DOI: 10.1093/nutrit/nuad020
Abstract: CONTEXT Atherosclerosis is a systemic pro-inflammatory and pro-oxidative disease, accounting for approximately a third of deaths globally. It has been proposed that omega-3s, through their antioxidant and anti-inflammatory properties, mitigate atherosclerotic disease progression. However, due… read more here.
Keywords: blood levels; atherosclerotic disease; disease; levels omega ... See more keywords
Periodontal diseases and association with atherosclerotic disease.
Sign Up to like & getrecommendations! Published in 2020 at "Periodontology 2000"
DOI: 10.1111/prd.12302
Abstract: Cardiovascular diseases still account for the majority of deaths worldwide, although significant improvements in survival, after being affected by cardiovascular disease, have been achieved in the last decades. Periodontal diseases are also a common global burden.… read more here.
Keywords: periodontal diseases; disease; evidence; atherosclerotic disease ... See more keywords
Increased incidence and treatment of intracranial atherosclerotic disease during mechanical thrombectomy is safe, even with an increased number of passes
Sign Up to like & getrecommendations! Published in 2021 at "Journal of NeuroInterventional Surgery"
DOI: 10.1136/neurintsurg-2020-017114
Abstract: Background The incidence of intracranial atherosclerotic disease (ICAD) in acute ischemic stroke treated with mechanical thrombectomy (MT) is not well defined, and its description may lead to improved stroke devices and rates of first pass… read more here.
Keywords: mechanical thrombectomy; intracranial atherosclerotic; disease; icad ... See more keywords
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications
Sign Up to like & getrecommendations! Published in 2023 at "Stroke and Vascular Neurology"
DOI: 10.1136/svn-2023-002333
Abstract: Intracranial atherosclerotic disease (ICAD) is a common cause of ischaemic stroke and transient ischaemic attack (TIA) with a high recurrence rate. It is often referred to as intracranial atherosclerotic stenosis (ICAS), when the plaque has… read more here.
Keywords: intracranial atherosclerotic; clinical implications; cerebral haemodynamics; atherosclerotic disease ... See more keywords
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
Sign Up to like & getrecommendations! Published in 2018 at "Arteriosclerosis, Thrombosis, and Vascular Biology"
DOI: 10.1161/atvbaha.118.310538
Abstract: Objective— CSL112 (apolipoprotein A-I [apoA-I; human]) is a novel formulation of apoA-I in development for reduction of early recurrent cardiovascular events after acute myocardial infarction. Cholesterol efflux capacity (CEC) is a marker of high-density lipoprotein… read more here.
Keywords: csl112; cholesterol; disease; atherosclerotic disease ... See more keywords
False Utopia of One Unifying Description of the Vulnerable Atherosclerotic Plaque: A Call for Recalibration That Appreciates the Diversity of Mechanisms Leading to Atherosclerotic Disease.
Sign Up to like & getrecommendations! Published in 2022 at "Arteriosclerosis, thrombosis, and vascular biology"
DOI: 10.1161/atvbaha.121.316693
Abstract: Atherosclerosis is a complex disease characterized by the formation of arterial plaques with a broad diversity of morphological phenotypic presentations. Researchers often apply one description of the vulnerable plaque as a gold standard in preclinical… read more here.
Keywords: disease; diversity; atherosclerotic disease; one unifying ... See more keywords